PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 201 filers reported holding PTC THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $9,987,657 | -15.0% | 245,578 | +1.2% | 1.22% | -18.8% |
| Q1 2023 | $11,753,433 | +68.6% | 242,639 | +32.8% | 1.50% | +60.8% |
| Q4 2022 | $6,972,361 | -63.5% | 182,666 | -51.9% | 0.93% | -63.6% |
| Q3 2022 | $19,080,000 | +0.9% | 380,089 | -19.5% | 2.56% | +22.1% |
| Q2 2022 | $18,907,000 | +42.5% | 471,978 | +32.7% | 2.10% | +67.2% |
| Q1 2022 | $13,270,000 | -6.3% | 355,661 | +0.0% | 1.26% | +12.4% |
| Q4 2021 | $14,166,000 | +6.3% | 355,660 | -0.7% | 1.12% | +0.4% |
| Q3 2021 | $13,328,000 | -17.5% | 358,193 | -6.2% | 1.11% | -14.5% |
| Q2 2021 | $16,149,000 | -11.4% | 382,038 | -0.8% | 1.30% | -18.7% |
| Q1 2021 | $18,230,000 | -18.1% | 385,014 | +5.5% | 1.60% | -15.5% |
| Q4 2020 | $22,266,000 | +111.4% | 364,837 | +61.9% | 1.90% | +113.4% |
| Q3 2020 | $10,535,000 | -12.7% | 225,355 | -5.3% | 0.89% | -16.8% |
| Q2 2020 | $12,069,000 | +40.2% | 237,865 | +23.3% | 1.07% | +5.0% |
| Q1 2020 | $8,608,000 | – | 192,953 | – | 1.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,750,000 | $84,053,000 | 7.32% |
| RTW INVESTMENTS, LP | 3,832,480 | $184,074,000 | 6.94% |
| Burrage Capital Management LLC | 195,725 | $9,401,000 | 6.30% |
| Asymmetry Capital Management, L.P. | 55,408 | $2,661,000 | 4.77% |
| SECTORAL ASSET MANAGEMENT INC | 328,738 | $15,789,000 | 2.36% |
| ARMISTICE CAPITAL, LLC | 758,000 | $36,407,000 | 2.10% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 114,000 | $5,470,000 | 1.97% |
| Opaleye Management Inc. | 191,000 | $9,174,000 | 1.80% |
| Sofinnova Investments, Inc. | 517,092 | $24,836,000 | 1.79% |
| Chubb Ltd | 8,180 | $393,000 | 1.68% |